tiprankstipranks
Advertisement
Advertisement

DE:6BG Stock Latest News

Lytix Biopharma Overhauls Board and Renews Capital Mandate at AGM
Company AnnouncementsLytix Biopharma Overhauls Board and Renews Capital Mandate at AGM
2d ago
6BG
Lytix Biopharma Grants Share Options to Board Member Under Incentive Plan
PremiumCompany Announcements
Lytix Biopharma Grants Share Options to Board Member Under Incentive Plan
7d ago
6BG
Lytix Biopharma Appoints New COO to Drive Next Growth Phase
PremiumCompany Announcements
Lytix Biopharma Appoints New COO to Drive Next Growth Phase
10d ago
6BG
Lytix Biopharma Calls April AGM and Proposes No 2025 Dividend
PremiumCompany Announcements
Lytix Biopharma Calls April AGM and Proposes No 2025 Dividend
22d ago
6BG
Lytix Biopharma Marks Pivotal 2025 With Strong Melanoma Data and Capital Raise
PremiumCompany Announcements
Lytix Biopharma Marks Pivotal 2025 With Strong Melanoma Data and Capital Raise
24d ago
6BG
Lytix to Unveil Final Phase II Melanoma Data on Ruxotemitide at AACR 2026
PremiumCompany AnnouncementsLytix to Unveil Final Phase II Melanoma Data on Ruxotemitide at AACR 2026
30d ago
6BG
Lytix Biopharma Registers Share Capital Increase After NOK 16.3 Million Offering
Premium
Company Announcements
Lytix Biopharma Registers Share Capital Increase After NOK 16.3 Million Offering
2M ago
6BG
Lytix Biopharma’s Oncolytic Peptide Platform Gains Visibility with New JITC Review
Premium
Company Announcements
Lytix Biopharma’s Oncolytic Peptide Platform Gains Visibility with New JITC Review
2M ago
6BG
Lytix Biopharma Advances Ruxotemitide Program as Strong Phase II Data and Cost Discipline Mark 2025
PremiumCompany Announcements
Lytix Biopharma Advances Ruxotemitide Program as Strong Phase II Data and Cost Discipline Mark 2025
2M ago
6BG
Lytix Biopharma Raises NOK 16.3 Million in Subsequent Share Offering
PremiumCompany Announcements
Lytix Biopharma Raises NOK 16.3 Million in Subsequent Share Offering
2M ago
6BG
Lytix Biopharma’s NOK 30 Million Subsequent Share Offering Closes Today
PremiumCompany Announcements
Lytix Biopharma’s NOK 30 Million Subsequent Share Offering Closes Today
2M ago
6BG
Lytix Biopharma Schedules Webcast for Fourth-Quarter and Second-Half 2025 Results
PremiumCompany Announcements
Lytix Biopharma Schedules Webcast for Fourth-Quarter and Second-Half 2025 Results
2M ago
6BG
Lytix Biopharma Launches Subsequent Share Offering Following NOK 61 Million Private Placement
PremiumCompany AnnouncementsLytix Biopharma Launches Subsequent Share Offering Following NOK 61 Million Private Placement
3M ago
6BG
Lytix Biopharma Wins Shareholder Backing for NOK 30m Offering and Conversion to Public Company
Premium
Company Announcements
Lytix Biopharma Wins Shareholder Backing for NOK 30m Offering and Conversion to Public Company
3M ago
6BG
Lytix Biopharma Registers NOK 61 Million Private Placement, Expands Share Capital
Premium
Company Announcements
Lytix Biopharma Registers NOK 61 Million Private Placement, Expands Share Capital
3M ago
6BG
Lytix Biopharma Calls EGM for NOK 30m Repair Offering and Conversion to Public Company
PremiumCompany Announcements
Lytix Biopharma Calls EGM for NOK 30m Repair Offering and Conversion to Public Company
3M ago
6BG
Insider-Linked Investor Takes Major Allocation in Lytix Biopharma Share Issue
PremiumCompany Announcements
Insider-Linked Investor Takes Major Allocation in Lytix Biopharma Share Issue
3M ago
6BG
Lytix Biopharma Lines Up NOK 30m Subsequent Share Offering After Private Placement
PremiumCompany Announcements
Lytix Biopharma Lines Up NOK 30m Subsequent Share Offering After Private Placement
3M ago
6BG
Lytix Biopharma Raises NOK 61 Million in Oversubscribed Private Placement and Plans Repair Offering
PremiumCompany Announcements
Lytix Biopharma Raises NOK 61 Million in Oversubscribed Private Placement and Plans Repair Offering
3M ago
6BG
Lytix Biopharma’s Promising Update: Phase 2 Study on Advanced Melanoma Treatment Completed
PremiumCompany AnnouncementsLytix Biopharma’s Promising Update: Phase 2 Study on Advanced Melanoma Treatment Completed
4M ago
6BG
Lytix Biopharma to Release Q3 2025 Financial Results
Premium
Company Announcements
Lytix Biopharma to Release Q3 2025 Financial Results
5M ago
6BG
Lytix Biopharma Reports Promising Interim Results in Melanoma Study
Premium
Company Announcements
Lytix Biopharma Reports Promising Interim Results in Melanoma Study
5M ago
6BG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >